CEFAZOLIN FOR INJECTION : Vials may be underfilled in the affected lot.
Last updated
Summary
Product
CEFAZOLIN FOR INJECTION USP 10 G / VIAL
Issue
Health products - Product quality
What to do
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Affected products
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot number |
|---|---|---|---|---|
CEFAZOLIN FOR INJECTION USP |
DIN 02308967 |
Powder For Solution |
CEFAZOLIN SODIUM 10 G / VIAL |
PT6813 |
Issue
Vials may be underfilled in the affected lot.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers, Health Care Establishments
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Sandoz Canada Inc. 4600, rue Armand-Frappier, Saint-Hubert, QC, Canada, J3Z 1G5
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type I
Recall date
Identification number
RA-81620
Get notified
Receive emails about new and updated recall and safety alerts.